Listeria monocytogenes (Lm)-LLO immunotherapies reduce the immunosuppressive activity of myeloid-derived suppressor cells and regulatory T cells in the tumor microenvironment

Anu Wallecha; Inga Malinina; Poonam Molli

首页> 外文期刊>Journal for ImmunoTherapy of Cancer >Listeria monocytogenes (Lm)-LLO immunotherapies reduce the immunosuppressive activity of myeloid-derived suppressor cells and regulatory T cells in the tumor microenvironment

【24h】

Listeria monocytogenes (Lm)-LLO immunotherapies reduce the immunosuppressive activity of myeloid-derived suppressor cells and regulatory T cells in the tumor microenvironment

机译：单核细胞增生李斯特菌（Lm）-LLO免疫疗法可降低肿瘤微环境中髓样来源的抑制细胞和调节性T细胞的免疫抑制活性

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Journal for ImmunoTherapy of Cancer 》 |2013年第s1期| 1-1| 共1页
作者
Anu Wallecha; Inga Malinina; Poonam Molli;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. Listeria monocytogenes (lm)-llo immunotherapies reduce the immunosuppressive activity of myeloid-derived suppressor cells and regulatory t cells in the tumor microenvironment [J] . WallechaA., SinghR., MalininaI. Journal of immunotherapy . 2013 ,第9期

机译：李斯特菌（lm）-llo免疫疗法可降低肿瘤微环境中髓样来源的抑制细胞和调节性t细胞的免疫抑制活性
2. Listeria monocytogenes (Lm)-LLO immunotherapies reduce the immunosuppressive activity of myeloid-derived suppressor cells and regulatory T cells in the tumor microenvironment [J] . Anu Wallecha, Inga Malinina, Poonam Molli Journal for ImmunoTherapy of Cancer . 2013 ,第S1期

机译：histeria单核细胞增生（LM）-LLO免疫疗法减少肿瘤微环境中粘粒源抑制细胞和调节T细胞的免疫抑制活性
3. The nitric oxide radical scavenger carboxy-PTIO reduces the immunosuppressive activity of myeloid-derived suppressor cells and potentiates the antitumor activity of adoptive cytotoxic T lymphocyte immunotherapy [J] . Hirano Kosuke, Hosoi Akihiro, Matsushita Hirokazu, Oncoimmunology. . 2015 ,第8期

机译：一氧化氮自由基清除剂羧基-PTIO降低了髓样抑制细胞的免疫抑制活性，并增强了过继细胞毒性T淋巴细胞免疫疗法的抗肿瘤活性
4. Depleting Myeloid-derived Suppressor Cells with Janus Synthetic Nanoparticle Antibodies As A Cancer Immunotherapy [C] . Jiaying Liu, Pallab Pradhan, Randall Toy, Society for Biomaterials annual meeting and exposition . 2019

机译：用Janus合成纳米颗粒抗体耗尽骨髓来源的抑制细胞作为癌症免疫治疗。
5. The Immune Checkpoint B7x Promotes the Induction of Regulatory T Cells in the Tumor Microenvironment and Mediates Resistance to Immunotherapy [D] . John, Peter. 2022

机译：免疫检查点B7X促进肿瘤微环境中调节性T细胞的诱导，并介导对免疫疗法的抗性
6. Listeria monocytogenes (Lm)-LLO immunotherapies reduce the immunosuppressive activity of myeloid-derived suppressor cells and regulatory T cells in the tumor microenvironment [O] . Anu Wallecha, Inga Malinina, Poonam Molli 2013

机译：单核细胞增生李斯特菌（Lm）-LLO免疫疗法可降低肿瘤微环境中髓样来源的抑制细胞和调节性T细胞的免疫抑制活性
7. Listeria monocytogenes (Lm)-LLO immunotherapies reduce the immunosuppressive activity of myeloid-derived suppressor cells and regulatory T cells in the tumor microenvironment [O] . 2013

机译：单核细胞增生李斯特菌（Lm）-LLO免疫疗法可降低肿瘤微环境中髓样来源的抑制细胞和调节性T细胞的免疫抑制活性
8. Role of Myeloid-Derived Suppressor Cells in the Immunotherapy of HER2/neu-Positive Breast Carcinomas [R] . Morales, J. K., Kmieciak, M., Manjili, M. H. 2009

机译：髓源性抑制细胞在HER2 / neu阳性乳腺癌免疫治疗中的作用

Listeria monocytogenes (Lm)-LLO immunotherapies reduce the immunosuppressive activity of myeloid-derived suppressor cells and regulatory T cells in the tumor microenvironment

著录项

相似文献

相关主题

期刊订阅